ADDICTIONS CAG PUBLICATIONS 2015
Agboola S.A. Coleman T. McNeill A. Leonardi-Bee J. (2015). Abstinence and relapse amongst smokers who use varenicline in a quit attempt - a pooled analysis of randomized controlled trials. Addiction. 110(7):1182-1193. doi: 10.1111/add.12941.
Agrawal A. Lynskey M.T. Kapoor M. Bucholz K.K. Edenberg H.J. Schuckit M. Brooks A. Hesselbrock V. Kramer J. Saccone N. Tischfield J. Bierut L.J. (2015). Are genetic variants for tobacco smoking associated with cannabis involvement? Drug and Alcohol Dependence. 150(1):183-187. doi: 10.1016/j.drugalcdep.2015.02.029.
Ambresin G. Palmer V. Densley K. Dowrick C. Gilchrist G. Gunn J. (2015). What factors influence long-term antidepressant use in primary care? Findings from the Australian diamond cohort study. Journal of Affective Disorders.176:125-132. doi: 10.1016/j.jad.2015.01.055.
Babor T. Strang J. West R. (2015). Building the connections between science, practice and policy: Griffith Edwards and the UK National Addiction Centre. Addiction. 110 (Suppl 2):1-3. doi: doi.org/10.1111/add.12928.
Bailey M.J. Bradshaw R. Francese S. Salter T.L. Costa C. Ismail M. P. Webb R. Bosman I. Wolff K. de Puit M. (2015). Rapid detection of cocaine, benzoylecgonine and methylecgonine in fingerprints using surface mass spectrometry. Analyst. 140(18):6254-6259. doi: 10.1039/C5AN00112A.
Bains M. Venn A. Murray R.L. McNeill A. Jones L.L. (2015). ‘You just went in and you got it all sorted straightaway’ – what is the appeal of a community-based mobile Stop Smoking Service? Journal of Smoking Cessation. 10(1):65-73. doi: 10.1017/jsc.2013.38.
Beard E. Brown J. McNeill A. Michie S. West R. (2015). Has growth in electronic cigarette use by smokers been responsible for the decline in use of licensed nicotine products? Findings from repeated cross-sectional surveys. Thorax. 70(10):974-978. doi: 10.1136/thoraxjnl-2015-206801.
Beard E. Bruguera C. McNeill A. Brown J. West R. (2015). Association of amount and duration of NRT use in smokers with cigarette consumption and motivation to stop smoking: A national survey of smokers in England. Addictive Behaviors. 40: 33-38. doi: 10.1016/j.addbeh.2014.08.008.
Beard E. Brown J. West R. Acton C. Brennan A. Drummond C. Hickman M. Holmes J. Kaner E. Lock K. Walmsley M. Michie S. (2015). Protocol for a national monthly survey of alcohol use in England with 6-month follow-up: 'The Alcohol Toolkit Study'. BMC Public Health. 15:230. doi: 10.1186/s12889-015-1542-7.
Bendtsen P. Anderson P. Wojnar M. Newbury-Birch D. Müssener U. Colom J. Karlsson N. Brzózka K. Spak F. Deluca P. Drummond C. Kaner E. Kłoda K. Mierzecki A. Okulicz-Kozaryn K. Parkinson K. Reynolds J. Ronda G. Segura L. Palacio J.n Baena B. Slodownik L. van Steenkiste B. Wolstenholme A. Wallace P. Keurhorst M.N. Laurant M.G. Gual A. (2015). Professional's Attitudes Do Not Influence Screening and Brief Interventions Rates for Hazardous and Harmful Drinkers: Results from ODHIN Study. Alcohol and Alcoholism. 50(4):430-437. doi: 10.1093/alcalc/agv020.
Bird S.M. Parmar M.K. Strang J. (2015). Take-home naloxone to prevent fatalities from opiate-overdose: Protocol for Scotland's public health policy evaluation, and a new measure to assess impact. Drugs. 22(1):66-76. doi: 10.3109/09687637.2014.981509.
Bogdanovica I. Szatkowski L. McNeill A. Spanopoulos D. Britton J. (2015). Exposure to point-of-sale displays and changes in susceptibility to smoking: findings from a cohort study of school students. Addiction. 110(4):693–702. doi: 10.1111/add.12826.
Bogdanowicz K.M. Stewart R. Broadbent M. Hatch S.L. Hotopf M. Strang J. Hayes R.D. (2015). Double trouble: Psychiatric comorbidity and opioid addiction-all-cause and cause-specific mortality. Drug and Alcohol Dependence. 148:85-92. doi: 10.1016/j.drugalcdep.2014.12.025.
Boniface S. Scantlebury R. Watkins S.J. (2015). Health implications of transport: Evidence of effects of transport on social interactions. Journal of Transport and Health. 2(3):441-446. doi: 10.1016/j.jth.2015.05.005.
Breindahl T. Evans-Brown M. Hindersson P. McVeigh J. Bellis M. Stensballe A. Kimergård A. (2015). Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet. Drug Testing and Analysis. 7(2):164-172. doi: 10.1002/dta.1655.
Brose L.S. (2015). E-cigarettes may help smokers stop or reduce smoking. Evidence-Based Medicine. 20(4):134. doi: 10.1136/ebmed-2015-110179.
Brose L.S. Brown J. Hitchman S.C. McNeill A. (2015). Perceived relative harm of electronic cigarettes over time and impact on subsequent use. A survey with 1-year and 2-year follow-ups. Drug and Alcohol Dependence.157:106-111. doi: 10.1016/j.drugalcdep.2015.10.014.
Brose L.S. Hitchman S.C. Brown J. West R. McNeill A. (2015). Is use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1-year follow-up. Addiction. 110(7):1160-1168. doi: 10.1111/add.12917.
Brose L.S. McEwen A. Michie S. West R. Chew X.Y. Lorencatto F. (2015). Treatment manuals, training and successful provision of stop smoking behavioural support. Behaviour Research and Therapy. 71:34-39. doi: 10.1016/j.brat.2015.05.013.
Calder R. Hitchman S. Rooke C. McNeill A. (2015). Closing the Doors on Tobacco Promotion: An assessment of small retailer preparations for tobacco point of sale display removal and longer-term tobaccodisinvestment. Institute of Psychiatry, Psychology & Neuroscience, King’s College London. UK Centre for Tobacco & Alcohol Studies. Commissioned by Cancer Research UK.
Campbell G. Nielsen S. Bruno R. Lintzeris N. Cohen M. Hall W. Larance B. Mattick R.P. Degenhardt L. (2015). The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain. 156(2):231-242. doi: 10.1097/01.j.pain.0000460303.63948.8e.
Campbell G. Nielsen S. Larance B. Bruno R. Mattick R. Hall W. Lintzeris N. Cohen M. Smith K. Degenhardt L. (2015). Pharmaceutical opioid use and dependence among people living with chronic pain: Associations observed within the Pain and Opioids in Treatment (POINT) Cohort. Pain Medicine. 16(9):1745-1758. doi: 10.1111/pme.12773.
Carah N. Meurk C. Hall W. (2015). Profiling Hello Sunday Morning: who are the participants? International Journal of Drug Policy. 26(2):214-216.
Carey C.E. Agrawal A. Zhang B. Conley E.D. Degenhardt L. Heath A.C. Li D. Lynskey M.T. Martin N.G. Montgomery G.W. Wang T. Bierut L.J. Hariri A.R. Nelson E.C. Bogdan R. (2015). Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. Journal of Abnormal Psychology. 124(4):860-877. doi: 10.1037/abn0000079.
Carter A. Liddle J. Hall W. Chenery H. (2015). Mobile phones in research and treatment: Ethical guidelines and future directions. Journal of Medical Internet Research Mhealth Uhealth. 3(4):e95 doi: 10.2196/mhealth.4538.
Chatzimichali E.A. Gribble S. Jones P. Krishnappa N. Mason L.E. Miller R. Morley K.I. Parthiban V. Prigmore E. Rajan D. Sifrim A. Swaminathan G.J. Tivey A.R. Middleton A. Parker M. Carter N.P. Barrett J.C. Hurles M.E. FitzPatrick D.R. Firth H.V.; on behalf of the DDD study. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet. 385(9975):1305-1314. doi: 10.1016/S0140-6736(14)61705-0.
Chen V.C. Wu M.H. Lin T.Y. Ho Y.F. Wang H.Y. Gossop M. (2015). Comparison of socio-demographic characteristics, substance, and depression among male heroin users attending therapeutic community and methadone maintenance treatment program in Nantou, Taiwan. Substance Abuse Treatment, Prevention, and Policy. 10:41. doi: 10.1186/s13011-015-0037-y.
Connor J.P. Hall W. (2015). Alcohol burden in low-income and middle-income countries. Lancet. 386(10007):1922-1924. doi: 10.1016/S0140-6736(15)00236-6.
Cordell H.J. Han Y. Mells G.F. Li Y. Hirschfield G.M. Greene C.S. Xie G. Juran B.D. Zhu D. Qian D.C. Floyd J.A. Morley K.I. Prati D. Lleo A. Cusi D. Canadian-US PBC Consortium. Italian PBC Genetics Study Group. UK-PBC Consortium. Gershwin M.E. Anderson C.A. Lazaridis K.N. Invernizzi P. Seldin M.F. Sandford R.N., Amos C.I. Siminovitch K.A. (2015). International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nature Communications. 6:8019. doi: 10.1038/ncomms9019.
Cowie G.A. Swift E. Partos T. Borland R. (2015). Quitting activity and tobacco brand switching: findings from the ITC-4 Country Survey. Australia and New Zealand Journal of Public Health. 39(2):109-113. doi: 10.1111/1753-6405.12323.
Cowie G.A. Swift E. Partos T. Borland R. (2015). Unpicking causal possibilities: authors' response to Caldwell. Australia and New Zealand Journal of Public Health. 39(2):115. doi: 10.1111/1753-6405.12383.
The Deciphering Developmental Disorders Study (2015). Large-scale discovery of novel genetic causes of developmental disorders. Nature. 519(7542):223-228. doi: 10.1038/nature14135.
Day E. Copello A. Hull M. (2015). Assessment and management of alcohol use disorders. British Medical Journal. 19;350:h715. doi: 10.1136/bmj.h715.
Degenhardt L. Larney S. Kimber J. Farrell M. Hall W. (2015). Excess mortality among opioid-using patients treated with oral naltrexone in Australia. Drug and Alcohol Review. 34(1):90-96. doi: 10.1111/dar.12205.
Degenhardt L. Lintzeris N. Campbell G. Bruno R. Cohen M. Farrell M. Hall W.D. (2015). Experience of adjunctive cannabis use for chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study. Drug and Alcohol Dependence.147:144-150. doi: 10.1016/j.drugalcdep.2014.11.031.
Degenhardt L. Bruno R. Lintzeris N. Hall W. Nielsen S. Larance B. Cohen M. Campbell G. (2015). Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study. Lancet Psychiatry. 2(4):314-322. doi: 10.1016/S2215-0366(15)00005-X.
Degenhardt L. Romaniuk H. Coffey C. Hall W.D. Swift W. Carlin J.B. O'Loughlin C. Patton G.C. (2015). Does the social context of early alcohol use affect risky drinking in adolescents? Prospective cohort study. BMC Public Health. 15:1137. doi: 10.1186/s12889-015-2443-5.
Delforterie M.J. Creemers H.E. Agrawal A. Lynskey M.T. Jak S. Huizink A.C. (2015). The influence of age and gender on the likelihood of endorsing cannabis abuse/dependence criteria. Addictive Behaviors. 42:172-175. doi: 10.1016/j.addbeh.2014.11.029.
Delforterie M.J. Lynskey M.T. Huizink A.C. Creemers H.E. Grant J.D. Few L.R. Glowinski A.L. Statham D.J. Trull T.J. Bucholz K.K. Madden P.A. Martin N.G. Heath A.C. Agrawal A. (2015). The relationship between cannabis involvement and suicidal thoughts and behaviors. Drug and Alcohol Dependence. 150(1):98-104. doi: 10.1016/j.drugalcdep.2015.02.019.
Delgadillo J. Gore S. Ali S. Ekers D. Gilbody S. Gilchrist G. McMillan D. Hughes E. (2015). Feasibility randomized controlled trial of cognitive and behavioral interventions for depression symptoms in patients accessing drug and alcohol treatment. Journal of Substance Abuse Treatment. 55:6-14. doi: 10.1016/j.jsat.2015.02.008.
Deluca P. Coulton S. Alam M.F. Cohen D. Donoghue K. Gilvarry E. Kaner E. Maconochie I. McArdle P. McGovern R. Newbury-Birch D. Patton R. Phillips C. Phillips T. Russell I. Strang J. Drummond C. (2015). Linked randomised controlled trials of face-to-face and electronic brief intervention methods to prevent alcohol related harm in young people aged 14-17 years presenting to Emergency Departments (SIPS junior). BMC Public Health.15(1):345. doi: 10.1186/s12889-015-1679-4.
Di Forti M. Vassos E. Lynskey M. Craig M. Murray R.M. (2015). Cannabis and psychosis - Authors' reply. Lancet Psychiatry. 2(5):382. doi: 10.1016/S2215-0366(15)00177-7.
Di Forti M. Marconi A. Carra E. Fraietta S. Trotta A. Bonomo M. Bianconi F. Gardner-Sood P. O'Connor J. Russo M. Stilo S.A. Marques T.R. Mondelli V. Dazzan P. Pariante C. David A.S. Gaughran F. Atakan Z. Iyegbe C. Powell J. Morgan C. Lynskey M. Murray R.M. (2015). Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry. 2(3):233-238. doi: 10.1016/S2215-0366(14)00117-5.
Donoghue K. Elzerbi C. Saunders R. Whittington C. Pilling S. Drummond C. (2015).The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis. Addiction. 110(6):920-930. doi: 10.1111/add.12875.
Douglas H. Hall W. Gartner C. (2015). E-cigarettes and the law in Australia. Australian Family Physician. 44(6):415-418.
Eastwood B. Dockrell M.J. Arnott D. Britton J. Cheeseman H. Jarvis M.J. McNeill A. (2015). Electronic cigarette use in young people in Great Britain 2013-2014. Public Health. 129(9):1150-1156.
Elzerbi C. Donoghue K. Drummond C. (2015). A comparison of the efficacy of brief interventions to reduce hazardous and harmful alcohol consumption between European and non-European countries: a systematic review and meta-analysis of randomized controlled trials. Addiction. 110(7):1082-1091. doi: 10.1111/add.12960.
Farmer R.F. Seeley J.R. Kosty D.B. Gau J.M. Duncan S.C. Lynskey M.T. Lewinsohn P.M. (2015). Internalizing and externalizing psychopathology as predictors of cannabis use disorder onset during adolescence and early adulthood. Psychology of Addictive Behaviors. [Epub ahead of print]. doi: 10.1037/adb0000059.
Farrell M. Hall W. (2015). Heroin-assisted treatment: has a controversial treatment come of age? British Journal of Psychiatry. 207(1):3-4. doi: 10.1192/bjp.bp.114.160986.
Farrell M. Marsden J. Strang J. (2015). Griffith Edwards, the Addiction Research Unit and research on the criminal justice system. Addiction. 110 (Suppl 2):54-8. doi: 10.1111/add.12910.
Fergusson D.M. Hall W. Boden J.M. Horwood L.J. (2015). Rethinking cigarette smoking, cannabis use, and psychosis. Lancet Psychiatry. 2(7):581-582. doi: 10.1016/S2215-0366(15)00208-4.
Few L.R. Miller J.D. Grant J.D. Maples J. Trull T.J. Nelson E.C. Oltmanns T.F. Martin N.G. Lynskey M.T. Agrawal A. (2015). Trait-based assessment of borderline personality disorder using the NEO Five-Factor Inventory: Phenotypic and genetic support. Psychological Assessment. 28(1):39-50. doi: 10.1037/pas0000142.
Few L.R. Werner K.B. Sartor C.E. Grant J.D. Trull T.J. Nock M.K. Bucholz K.K. Deitz S.K. Glowinski A.L. Martin N.G. Nelson E.C. Statham D.J. Madden P.A. Heath A.C. Lynskey M.T. Agrawal A. (2015). Early Onset Alcohol Use and Self-Harm: A Discordant Twin Analysis. Alcoholism: Clinical and Experimental Research. 39(11):2134-2142. doi: 10.1111/acer.12889.
Fleetwood J. Radcliffe P. Stevens A. (2015). Shorter sentences for drug mules: The early impact of the sentencing guidelines in England and Wales. Drugs: Education, Prevention and Policy. 22(5): 428-436. doi: 10.3109/09687637.2015.1011607.
Forlini C. Hall W. (2015). The is and ought of the ethics of neuroenhancement: Mind the gap. Frontiers in Psychology. 6:1998. doi: 10.3389/fpsyg.2015.01998.
Gartner C. Hall W. (2015). A licence to vape: Is it time to trial of a nicotine licensing scheme to allow Australian adults controlled access to electronic cigarettes devices and refill solutions containing nicotine? International Journal of Drug Policy. 26(6):548-553. doi: 10.1016/j.drugpo.2015.02.003.
Gartner C. Hall W. (2015). Tobacco harm reduction in people with serious mental illnesses. Lancet Psychiatry. 2(6):485-487. doi: 10.1016/S2215-0366(15)00238-2.
Gilburt H. Drummond C. Sinclair J. (2015). Navigating the Alcohol Treatment Pathway: A qualitative study from the service users' perspective. Alcohol and Alcoholism. 50(4):444-450. doi: 10.1093/alcalc/agv027.
Gilchrist. G. Tirado J. Easton C. (2015). Should we reconsider anger management when addressing physical intimate partner violence perpetration by alcohol abusing males? A systematic review. Aggression and Violent Behavior. 25:124-132. doi: 10.1016/j.avb.2015.07.008.
Gilchrist G. Radcliffe P. McMurran M. Gilchrist L. (2015). The need for evidence-based responses to address intimate partner violence perpetration among male substance misusers. Criminal Behaviour and Mental Health. 25(4):233-238. doi: 10.1002/cbm.1980.
Gilchrist G. Singleton N. Donmall M. Jones A. (2015). Prevalence and factors associated with sex trading in the year prior to entering treatment for drug misuse in England. Drug and Alcohol Dependence. 152:116-122. doi: 10.1016/j.drugalcdep.2015.04.017.
Gilchrist G. Davidson S. Middleton A. Herrman H. Hegarty K. Gunn J. (2015). Factors associated with smoking and smoking cessation among primary care patients with depression: a naturalistic cohort study. Advances in Dual Diagnosis. 8:18-28. doi: 10.1108/ADD-10-2014-0036.
Gilchrist G. Blazquez A. Segura L. Geldschläger H. Valls E. Colom J. Torrens M. (2015). Factors associated with physical or sexual intimate partner violence perpetration by men attending substance misuse treatment in Catalunya: A mixed methods study. Criminal Behaviour and Mental Health. 25(4):239-257. doi: 10.1002/cbm.1958.
Gossop M. (2015). The National Treatment Outcomes Research Study (NTORS) and its influence on addiction treatment policy in the United Kingdom. Addiction. 110 (Suppl 2):50-53. doi: 10.1111/add.12906.
Gowing L.R. Ali R.L. Allsop S. Marsden J. Turf E.E. West R. Witton J. (2015). Global statistics on addictive behaviours: 2014 status report. Addiction. 110(6):904-919. doi: 10.1111/add.12899.
Grace F.C. Meurk C.S. Head B.W. Hall W.D. Carstensen G. Harris M.G. Whiteford H.A. (2015). An analysis of policy levers used to implement mental health reform in Australia 1992-2012. BMC Health Services Research. 15:479.
Grant J.D. Lynskey M.T. Madden P.A. Nelson E.C. Few L.R. Bucholz K.K. Statham D.J. Martin N.G. Heath A.C. Agrawal A. (2015). The role of conduct disorder in the relationship between alcohol, nicotine and cannabis use disorders. Psychological Medicine. 45(16):3505-3515.
Hall W. (2015). Challenges in minimizing the adverse effects of cannabis use after legalization. Social Psychiatry and Psychiatric Epidemiology. 50(7):1013-1015.
Hall W. (2015). Getting to grips with the cannabis problem: the evolving contributions and impact of Griffith Edwards. Addiction. 10 (Suppl 2):36-39.
Hall W. (2015). U.S. policy responses to calls for the medical use of cannabis. Yale Journal of Biology and Medicine. 88(3):257-264.
Hall W. (2015). What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction. 110(1):19-35
Hall W. Degenhardt L. (2015). High potency cannabis: a risk factor for dependence, poor psychosocial outcomes, and psychosis. British Medical Journal. 350:h1205.
Hall W. Morley K. (2015). Possible causes and consequences of reduced perceptions of the risks of using cannabis. Clinical Toxicology. 53(3):141-142
Hall W. Weier M. (2015). Assessing the public health impacts of legalizing recreational cannabis use in the USA. Clinical Pharmacology and Therapeutics. 97(6):607-615.
Hall W. Carter A. Forlini C. (2015). The brain disease model of addiction: is it supported by the evidence and has it delivered on its promises? Lancet Psychiatry. 2(1):105-110.
Hall W. Carter A. Forlini C. (2015). The brain disease model of addiction: challenging or reinforcing stigma?--Authors' reply. Lancet Psychiatry. 2(4):292.
Hall W. Carter A. Forlini C. (2015). Brain disease model of addiction: misplaced priorities? Lancet Psychiatry. 2(10):867.
Hall W. Gartner C. Forlini C. (2015). Nuances in the ethical regulation of electronic nicotine delivery systems. Addiction. 110(7):1074-1075.
Hall N. Thuy L.N. Diem Tdo T. Waters A. Dunford L. Connell J. Carr M. Hall W. Thi L.A. (2015). High prevalence of hepatitis delta virus among persons who inject drugs, Vietnam. Emerging Infectious Diseases. 21(3):540-543.
Heslin M. Lomas B. Lappin J.M. Donoghue K. Reininghaus U. Onyejiaka A. Croudace T, Jones P.B. Murray R.M. Fearon P. Dazzan P. Morgan C. Doody G.A. (2015). Diagnostic change 10 years after a first episode of psychosis. Psychological Medicine. 45(13):2757-2769.
Hines L. Morley K.I. Mackie C. Lynskey M. (2015). Genetic and environmental interplay in adolescent substance use disorders. Current Addiction Reports. 2:122–129.
Hines L.A. Morley K.I. Strang J. Agrawal A. Nelson E.C. Statham D. Martin N.G. Lynskey M.T. (2015). The association between speed of transition from initiation to subsequent use of cannabis and later problematic cannabis use, abuse and dependence. Addiction. 110(8):1311- 1320.
Hitchman S.C. Brose L.S. Brown J. Robson D. McNeill A. (2015). Associations between e-cigarette type, frequency of use, and quitting smoking: Findings from a longitudinal online panel survey in Great Britain. Nicotine and Tobacco Research. 17(10):1187-1194.
Hughes L. Fitzgerald C. Radcliffe P. Gilchrist G. (2015). A framework for working safely and effectively with men who perpetrate intimate partner violence in substance use treatment settings. London: King’s College London.
Hummel K. Nagelhout G.E. Willemsen M.C. Driezen P. Springvloet L. Mons U. Kunst A.E. Guignard R. Allwright S. van den Putte B. Hoving C. Fong G.T. McNeill A. Siahpush M. de Vries H. (2015). Drug and Alcohol Dependence. 155(1):154-162.
Im P.K. McNeill A. Thompson M.E. Fong G.T. Xu S. Quah A.C. Jiang Y. Shahab L. (2015). Individual and interpersonal triggers to quit smoking in China: a cross-sectional analysis. Tobacco Control. 24(Suppl 4):iv40-iv47.
Jolley C.J. Bell J. Rafferty G.F. Moxham J. Strang J. (2015). Understanding heroin overdose: A study of the acute respiratory depressant effects of injected pharmaceutical heroin. PLoS One. 10(10):e0140995.
Kelly A.B. Evans-Whipp T.J. Smith R. Chan G.C. Toumbourou J.W. Patton G.C. Hemphill S.A. Hall W.D. Catalano R.F. (2015). A longitudinal study of the association of adolescent polydrug use, alcohol use and high school non-completion. Addiction. 110(4):627-635.
Khadjesari Z. Newbury-Birch D. Murray E. Shenker D. Marston L. Kaner E. (2015). Online health check for reducing alcohol intake among employees: a feasibility study in six workplaces across England. PLoS One. 10(3): e0121174.
Khadjesari Z. Stevenson F. Godfrey C. Murray E. (2015). Negotiating the 'grey area between normal social drinking and being a smelly tramp': a qualitative study of people searching for help online to reduce their drinking. Health Expectations. 18(6): 2011–2020.
Kimergård A. Walker C. Cowan D. (2015). Potent and untested drugs sold as dietary supplements (letter). BMJ.351:h418.
Kruse G.R. Rigotti N.A. Raw M. McNeill A. Murray R. Piné-Abata H. Bitton A. McEwen A. (2015). Tobacco dependence treatment training programs: An international survey. Nicotine and Tobacco Research. 18(5):1012-1018.
Lewis S. Sims M. Richardson S. Langley T. Szatkowski L. McNeill A. Gilmore A.B. (2015). The effectiveness of tobacco control television advertisements in increasing the prevalence of smoke-free homes. BMC Public Health. 15:869.
Li L. Borland R. Yong H. Cummings K.M. Thrasher J.F. Hitchman S.C. Fong G.T. Hammond D. Bansal-Travers M. (2015). Longer term impact of cigarette package warnings in Australia compared with the United Kingdom and Canada. Health Education Research. 30(1):67-80.
Lynskey M.T. Kimber J. Strang J. (2015). Drug-related mortality in psychiatric patients. Lancet Psychiatry. 2(9):767-769.
McNeill A, Brose L.S. Calder R. Hitchman S.C. Hajek P. McRobbie H. (2015). Ann McNeill and colleagues reply to Martin McKee and Simon Capewell. BMJ. 351:h5010.
McNeill A. Brose L.S. Calder R. Hitchman S.C. Hajek P. McRobbie H. (2015). E-cigarettes: the need for clear communication on relative risks. Lancet. 386(10000):1237.
McNeill A. Guignard R. Beck F. Marteau R. Marteau T.M. (2015). Understanding increases in smoking prevalence: case study from France in comparison with England 2000–10. Addiction. 110(3): 392–400.
Medhus S. Rognli E.B. Gossop M. Holm B. Mørland J. Bramness J.G. (2015). Amphetamine-induced psychosis: Transition to schizophrenia and mortality in a small prospective sample. American Journal on Addictions. 24(7):586-589.
Metrebian N. Groshkova T. Hellier J. Charles V. Martin A. Forzisi L. Lintzeris N. Zador D. Williams H. Carnwath T. Mayet S. Strang J. (2015). Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT). Addiction. 110(3):479-490.
Middleton A. Morley K.I. Bragin E. Firth H.V. Hurles M.E. Wright C.F. Parker M. on behalf of the Deciphering Developmental Disorders Study (2015). No expectation to share incidental findings in genomic research. Lancet. 385(9975):1289-1290.
Milward J. Day E. Wadsworth E. Strang J. Lynskey M. (2015). Mobile phone ownership, usage and readiness to use by patients in drug treatment. Drug and Alcohol Dependence. 146(1):111-115.
Morley K.I. Lynskey M.T. Moran P. Borschmann R. Winstock A.R. (2015). Polysubstance use, mental health and high-risk behaviours: Results from the 2012 Global Drug Survey. Drug and Alcohol Review. 34(4):427-437.
Morphett K. Partridge B. Gartner C. Carter A. Hall W. (2015). Why don't smokers want help to quit? A qualitative study of smokers' attitudes towards assisted vs. unassisted quitting. International Journal of Environmental Research and Public Health. 12(6):6591-6607.
Moss A.C. Albery I.P. Dyer K.R. Frings D. Humphreys K. Inkelaar T. Harding E. Speller A. (2015). The effects of responsible drinking messages on attentional allocation and drinking behaviour. Addictive Behaviors. 44: 94-101.
Munn-Chernoff M.A. Grant J.D. Bucholz K.K. Agrawal A. Lynskey M.T. Madden P.A. Heath A.C. Duncan A. (2015). Bulimic behaviors and early substance use: Findings from a Cotwin-Control Study. Alcoholism: Clinical and Experimental Research. 39(9):1740-1748.
Neale J. Stevenson C. (2015). Social and recovery capital amongst homeless hostel residents who use drugs and alcohol. International Journal of Drug Policy. 26(5): 475-483.
Neale J. Strang J. (2015). Blending qualitative and quantitative research methods to optimize patient reported outcome measures (PROMs). Addiction. 110(8):1215-1216.
Neale J. Strang J. (2015). Philosophical ruminations on measurement: methodological orientations of patient reported outcome measures (PROMS). Journal of Mental Health. 24(3):123-125.
Neale J. Strang J. (2015). Naloxone - does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose. Addiction. 110(10): 1644-1652.
Neale J. West R. (2015). Guidance for reporting qualitative manuscripts. Addiction. 110(4): 549-550.
Neale J. Tompkins C. Wheeler C. Finch E. Marsden J. Mitcheson L. Rose D. Wykes T. Strang J. (2015). “You're all going to hate the word 'recovery' by the end of this": Service users' views of measuring addiction recovery. Drugs: Education, Prevention and Policy. 22(1):26-34.
Pagliaccio D. Barch D.M. Bogdan R. Wood P.K. Lynskey M.T. Heath A.C. Agrawal A. (2015). Shared Predisposition in the Association Between Cannabis Use and Subcortical Brain Structure. JAMA Psychiatry. 72(10):994-1001.
Parry C.D. Deluca P. Cooper R. Van Hout M.C. (2015). Do we have sufficient information to optimally inform regulatory or other policy decisions about medications containing codeine? Addiction. 10(10):1690-1691.
Patton R. Donoghue K. (2015). Web-delivered personalised normative feedback for college students on alcohol consumption and sexual situations reduces alcohol-related risky sexual behaviour. Evidence-Based Nursing. 18(3):84.
Radcliffe, P. Hunter, G. (2015). ‘It was a safe place for me to be’. Accounts of attending Women’s Community Services and moving beyond the offender identity. British Journal of Criminology. doi: 10.1093/bjc/azv093 [Epub ahead of print].
Raupach T. Al-Harbi G. McNeill A. Bobak A. McEwen A. (2015). Smoking cessation education and training in UK medical schools: a national survey. Nicotine and Tobacco Research.17 (3): 372-375.
Reed K. Day E. Keen J. Strang J. (2015). Pharmacological treatments for drug misuse and dependence. Expert Opinion on Pharmacotherapy. 16( 3): 325-333.
Reininghaus U. Dutta R. Dazzan P. Doody G.A. Fearon P. Lappin J. Heslin M. Onyejiaka A. Donoghue K. Lomas B. Kirkbride J.B. Murray R.M. Croudace T. Morgan C. Jones P.B. (2015). Mortality in schizophrenia and other psychoses: a 10-year follow-up of the ӔSOP first-episode cohort. Schizophrenia Bulletin. 41(3):664-673.
Revier C.J. Reininghaus U. Dutta R. Fearon P. Murray R.M. Doody G.A. Croudace T. Dazzan P. Heslin M. Onyejiaka A. Kravariti E. Lappin J. Lomas B. Kirkbride J.B. Donoghue K. Morgan C. Jones P.B. (2015). Ten-year outcomes of first-episode psychoses in the MRC ÆSOP-10 study. Journal of Nervous and Mental Disease. 203(5):379-386.
Richmond-Rakerd L.S. Slutske W.S. Deutsch A.R. Lynskey M.T. Agrawal A. Madden P.A. Bucholz K.K. Heath A.C. Martin N.G. (2015). Progression in substance use initiation: A multilevel discordant monozygotic twin design. Journal of Abnormal Psychology. 124(3):596-605.
Sartor C.E. Agrawal A. Grant J.D. Duncan A.E. Madden P.A. Lynskey M.T. Heath A.C. Bucholz K.K. (2015). Differences between African-American and European-American women in the association of childhood sexual abuse with initiation of marijuana use and progression to problem use. Journal of Studies on Alcohol and Drugs. 76(4):569-577.
Shahab L. Gilchrist G. Hagger–Johnson G. Shankar A. West E. West R. (2015). Reciprocal associations between smoking cessation and depression in older smokers: findings from the English Longitudinal Study of Ageing (ELSA). British Journal of Psychiatry. 207(3):243-249.
Shiner M. Winstock A. (2015). Drug use and social control: The negotiation of moral ambivalence. Social Science and Medicine.138:248-256.
Stensballe A. McVeigh J. Breindahl T. Kimergård A. (2015). Synthetic growth hormone releasers detected in seized drugs: new trends in the use of drugs for performance enhancement. Addiction. 110(2):368-369.
Strang J. (2015). Death matters: understanding heroin/opiate overdose risk and testing potential to prevent deaths. Addiction. 110(Suppl 2):27-35.
Strang J. Groshkova T. Uchtenhagen A. van den Brink W. Haasen C. Schechter M.T. Lintzeris N. Bell J. Pirona A. Oviedo-Joekes E. Simon R. Metrebian N. (2015). Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. British Journal of Psychiatry. 207(1):5-14.
Szatkowski L, McNeill A. (2015). Diverging trends in smoking behaviours according to mental health status. Nicotine and Tobacco Research. 17(3): 356-360.
Tantirangsee N. Assanangkornchai S. Marsden J. (2015). Effects of a brief intervention for substance use on tobacco smoking and family relationship functioning in schizophrenia and related psychoses: a randomised controlled trial. Journal of Substance Abuse Treatment. 51:30-37.
Taylor G. Taylor A. Munafò M.R. McNeill A. Aveyard P. (2015). Does smoking reduction worsen mental health? A comparison of two observational approaches. BMJ Open. 5(5):e007812.
Teesson M. Marel C. Darke S. Ross J. Slade T. Burns L. Lynskey M. Memedovic S. White J. Mills K.L. (2015). Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-year findings from the Australian Treatment Outcome Study. Addiction. 110(6):986-993.
Tirado J. Gilchrist G. Lligoña E. Gilbert L. Torrens M. (2015). A group intervention to reduce intimate partner violence among female drug users. Results from a randomized controlled pilot trial in a community substance abuse center. Adicciones. 27(3):168-178.
Tombor I. Neale J. Shahab l. Ruiz M. West R. (2015). Healthcare Providers’ Views on Digital Smoking Cessation Interventions for Pregnant Women. Journal of Smoking Cessation. 10(2):116 – 123.
Tombor I. Shahab L. Herbec A. Neale J. Michie S. West R. (2015). Smoker identity and its potential role in young adults' smoking behavior: a meta-ethnography. Health Psychology. 34(10):992-1003.
Tsai C.J. Lee C.T. Liang S.H. Tsai P.J, Chen V.C. Gossop M. (2015). Risk of ADHD after multiple exposures to general anesthesia: A nationwide retrospective cohort study. Journal of Attention Disorder. pii: 1087054715587094. [Epub ahead of print].
van den Brink W. Strang J. Gual A. Sørensen P. Jensen T.J. Mann K. (2015). Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme. Expert Opinion on Drug Safety.14(4):495-504.
Venn A. Dickinson A. Murray R. Jones L. Li J. Parrott S. McNeill A. (2015). Effectiveness of a mobile, drop-in stop smoking service in reaching and supporting disadvantaged UK smokers to quit. Tobacco Control. 25 (1):33-38.
Waldron M. Doran K.A. Bucholz K.K. Duncan A.E. Lynskey M.T. Madden P.A. Sartor C.E. Heath A.C. (2015). Parental separation, parental alcoholism, and timing of first sexual intercourse. Journal of Adolescent Health. 56(5):550-556.
Way M. McQuillin A. Saini J. Ruparelia K. Lydall G.J. Guerrini I. Ball D. Smith I. Quadri G. Thomson A.D. Kasiakogia-Worlley K. Cherian R. Gunwardena P. Rao H. Kottalgi G. Patel S. Hillman A. Douglas E. Qureshi S.Y. Reynolds G. Jauhar S. O'Kane A. Dedman A. Sharp S. Kandaswamy R. Dar K. Curtis D. Morgan M.Y. Gurling H.M. (2015). Genetic variants in or near ADH1B and ADH1C affect susceptibility to alcohol dependence in a British and Irish population. Addiction Biology. 20(3):594–604.
Weaver T. Metrebian N. Strang J. (2015). Hepatitis B vaccination for people who inject drugs--authors' reply. Lancet. 385(9963):116.
West R. Marsden J. Darke S. Humphreys K. Miller P. Hall W. Petry N. (2015). Vote of thanks to Professor Tom Babor. Addiction. 110(7):1060.
West R. Raw M. McNeill A. Stead L. Aveyard P. Britton J. Stapleton J. McRobbie H. Pokhrel S. Lester-George A. Borland R. (2015). Healthcare interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development. Addiction. 110(9):1388-1403.
White M. Burton R. Darke S. Eastwood B. Knight J. Millar T. Musto V. Marsden J. (2015). Fatal opioid poisoning: a counterfactual model to estimate the preventive effect of treatment for opioid use disorder in England. Addiction. 110(8):1321-1329.
Wilson E. Lader M. (2015). A review of the management of antidepressant discontinuation symptoms. Therapeutic Advances in Psychopharmacology. 5(6):357-368.
Winstock A. Lynskey M. Borschmann R. Waldron J. (2015). Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample. Journal of Psychopharmacology. 29(6):698-703.
Winston I. McDonald R. Tas B. Strang J. (2015). Heroin overdose resuscitation with naloxone: patient uses own prescribed supply to save the life of a peer. BMJ Case Reports. 2015:21039.
Woodhead C. Aschan L. Lynskey M.T. Polling C. Goodwin L. Hatch S.L. (2015). Exploring evidence for a prospective relationship between common mental disorder and meeting residential mobility preferences. Health and Place. 32:19-28
Wright C.F. Fitzgerald T.W. Jones W.D. Clayton S. McRae J.F. van Kogelenberg M. King D.A. Ambridge K. Barrett D.M. Bayzetinova T. Bevan A.P. Bragin E. Chatzimichali E.A. Gribble S. Jones P. Krishnappa N. Mason L.E. Miller R. Morley K.I. Parthiban V. Prigmore E. Rajan D. Sifrim A. Swaminathan G.J. Tivey A.R. Middleton A. Parker M. Carter N.P. Barrett J.C. Hurles M.E. FitzPatrick D.R. Firth H.V; DDD Study. (2016). Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet. 385(9975):1305-1314.
Zavos H.M. Siribaddana S. Ball H.A. Lynskey M.T. Sumathipala A. Rijsdijk F.V. Hotopf M. (2015). The prevalence and correlates of alcohol use and alcohol use disorders: a population based study in Colombo, Sri Lanka. BMC Psychiatry. 15:158.